skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Jared Wolff, Jack Allen, and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.

 

 

Topics covered in this episode include:

  • Overview of data from Novartis's JULIET trial: CAR-T impact (KITE & JUNO) (0:45
  • Betrixiban's June 24th PDUFA (Portola) in prophylaxis of VTE (8:00)
  • Effect of Xtandi (Pfizer/Astellas) PROSPER trial amendments on prostate cancer market dynamic (Zytiga -JNJ mentioned) (15:12)
  • Scott Gottlieb's agenda as FDA commissioner: Five major policy points and the opioid epidemic (19:40)

 

 

Click here to listen 

 

 

To learn more about Datamonitor Healthcare and our offerings, visit: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare

 

Read also

  • Datamonitor Healthcare: data analysis and insight

    Pharma Must Not Let Its COVID-19 Halo Slip

    By Daniel Chancellor

    Biopharma’s accomplishments in tackling the global COVID-19 pandemic, unlike advances within oncology such as cell therapies and checkpoint inhibitors, or functional cures for HIV and hepatitis C, have captured the public’s imagination.

    Topics Coronavirus $name BioPharmaceutical

  • Datamonitor Healthcare: data analysis and insight, Pink Shee...

    Pharma Intelligence Podcasts

    Listen to the Pharma Intelligence podcasts on Spotify, Apple Podcasts, Soundcloud and Alexa

    Topics Coronavirus $name $name Clinical Trials Blog Clinical Trials Drug Pricing

  • Datamonitor Healthcare: data analysis and insight

    mHealth and Research in Oncology

    The World Health Organization defines mobile health (mHealth) as a “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices”. In the last decade, the health sector has seen a substantial rise in the number of mHealth apps, many of which are designed to assist users in weight reduction and diabetes management. In 2016, there were 79,000 apps available in the Health & Fitness category in the Google and Apple stores. However, the implementation of mHealth in oncology is lagging, and there are comparatively few available apps. There is a need for the development of more mHealth apps in oncology settings considering the increasing disease burden and potential clinical benefit. 

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: